Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 109 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Preclinical Development of ABBV-319: a CD19-targeting Glucocorticoid Receptor Modulator (GRM) Agonist Antibody-Drug Conjugate (ADC) for the Treatment of B-cell Malignancies
Chewei Anderson Chang, Ethan Emberley,Aloma L. D'Souza, Weilong Zhao,Cormac Cosgrove, Axel Hernandez Jr,Anatol Oleksijew, Paul Ellis,Luis Rodriguez,Gail Bukofzer, David Peetz,Wissam Assaily, Raghuveer Singh Mali, Wei Liu, Danqing Xu, Gregory K. Potts, Shaun McLoughlin, Kimberley McCarthy,Zhaomei Zhang,Jos Campbell, Isabella Sturdevant, Gloria Zhang, Tyler Curran, Jon D. Williams,Erwin Boghaert,Milan Bruncko,Christopher C. Marvin,Adrian Hobson, Michael Mcpherson,Tamar Uziel,Marybeth Pysz,Xi Zhao,Alex Bankovich,Kevin J. Freise,Susan Morgan-Lappe,James W. Purcell
Cancer Researchno. 7_Supplement (2023): 6308-6308
Cited0Views0Bibtex
0
0
Abstract 6311: ABBV-400: an ADC Delivering a Novel Topoisomerase 1 Inhibitor to C-Met-positive Solid Tumors
R. Reilly, Cheng Ji,Ryan P. Matuszak,Mark G. Anderson, L. Tucker, N. Klunder, Adelyn L. Lazo,E. Boghaert,Marybeth Pysz, A. D’Souza, Laura M. Kreckler, M. Bruncko,Brittney J. Mills, M. Ravn,George Doherty, K. Freise, A. Phillips
Cancer Research (2023)
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 109

#Citation: 6814

H-Index: 29

G-Index: 62

Sociability: 6

Diversity: 2

Activity: 27

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn